PDCD1 and melanoma: In a mouse melanoma model, it has been reported that an increase in IFN-γ and granzyme B production in NK cells and CD8+ T cells can be observed, and an increase in PD-1 Antitumor immune responses to immune checkpoint inhibitors by blocking LDH-A [99].